AI Driving Innovation: Insights From Exscientia CEO Andrew Hopkins

 
• By Lucie Ellis-Taitt and David Wild

Andrew Hopkins, founder and CEO of Exscientia, invented and championed an algorithmic approach to drug design and drug discovery. He talks to In Vivo about artificial intelligence in the biopharma industry today and what lies ahead. 

AI drug development concept
• Source: Shutterstock

More from Leadership

More from In Vivo